Search Results | Blood | American Society of Hematology

1-20 of 164

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease

Blood blood.2022019107.

DOI: https://doi.org/10.1182/blood.2022019107

Published: 2023

Includes: Supplemental data

Journal Articles

Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial

Blood (2022) 140 (Supplement 1): 2135–2136.

DOI: https://doi.org/10.1182/blood-2022-166996

Published: 2022

Journal Articles

Splenic Irradiation Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with Myelofibrosis

John R Bales, Haesook T Kim, Roxana Portillo, Chirayu Patel, Steven McAfee, Bimalangshu Dey, Thomas Spitzer, Yi-Bin Chen, Areej El-Jawahri, Zachariah Defilipp, Gabriela S. Hobbs

Blood (2022) 140 (Supplement 1): 12957–12958.

DOI: https://doi.org/10.1182/blood-2022-162478

Published: 2022

Journal Articles

Allogeneic Stem Cell Cryopreservation Is Associated with Equivalent Survival and Relapse Rates with Lower Rate of Severe Chronic Gvhd

Katie Maurer, Haesook T. Kim, Heather Garrity, Carol Reynolds, Deborah Liney, Augustine Weber, Joseph H. Antin, Corey Cutler, Jerome Ritz, John Koreth, Roman M. Shapiro, Rizwan Romee, Vincent Ho, Mahasweta Gooptu, Catherine J. Wu, Sarah Nikiforow, Robert J. Soiffer

Blood (2022) 140 (Supplement 1): 4804–4805.

DOI: https://doi.org/10.1182/blood-2022-162663

Published: 2022

Journal Articles

Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets

Blood (2022) 140 (Supplement 1): 4762–4764.

DOI: https://doi.org/10.1182/blood-2022-162841

Published: 2022

Journal Articles

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Blood (2022) 140 (Supplement 1): 917–919.

DOI: https://doi.org/10.1182/blood-2022-157611

Published: 2022

Journal Articles

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Blood (2022) 139 (24): 3546–3557.

DOI: https://doi.org/10.1182/blood.2021014520

Published: 2022

Includes: Supplemental data

Journal Articles

Phase II Clinical Trial of Abatacept for Steroid-Refractory Chronic Graft Versus Host Disease

Blood (2021) 138 (Supplement 1): 264.

DOI: https://doi.org/10.1182/blood-2021-148343

Published: 2021

Journal Articles

A Phase II Study of Ruxolitinib Pre-, during- and Post-Hematopoietic Celltransplantation for Patients with Primary or Secondary Myelofibrosis

Gabriela Hobbs, Haesook T. Kim, AJ S. Bottoms, Michael T. Byrne, Mark A. Schroeder, Roni Tamari, Sarah A Wall, Zachariah Defilipp, Areej El-Jawahri, Steven McAfee, Yi-Bin Chen

Blood (2021) 138 (Supplement 1): 169.

DOI: https://doi.org/10.1182/blood-2021-146330

Published: 2021

Journal Articles

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood (2021) 137 (23): 3212–3217.

DOI: https://doi.org/10.1182/blood.2021010867

Published: 2021

Includes: Supplemental data

Journal Articles

Early Reconstitution of CD6+ T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab

Benedetta Rambaldi, MD, Haesook T. Kim, PhD, Carol Reynolds, PhD, Sharmila Chamling Rai, BSc, Takeru Asano, MD PhD, Yohei Arihara, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Vincent T. Ho, MD, Joseph H. Antin, MD, Rizwan Romee, MD, Robert J. Soiffer, MD, Jeanette Ampudia, Cherie Tracy Ng, PhD MPH, Stephen Connelly, PhD MBA, Jerome Ritz, MD

Blood (2020) 136 (Supplement 1): 10–11.

DOI: https://doi.org/10.1182/blood-2020-138710

Published: 2020

Journal Articles

Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial

Roman M Shapiro, MD, Sarah Nikiforow, MD PhD, Benedetta Rambaldi, MD, Juliana Vergara, Heather Daley, Haesook T. Kim, PhD, Corey Cutler, MD MPH, FRCPC, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Mahasweta Gooptu, MD, Joseph H. Antin, MD, Jennifer Brock, Catherine J. Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Rizwan Romee, MD

Blood (2020) 136 (Supplement 1): 8–9.

DOI: https://doi.org/10.1182/blood-2020-133933

Published: 2020

Journal Articles

Defibrotide: Real World Experience for Management of Veno-Occlusive Disease/ Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplantation

Mary Nauffal, MS,PharmD, Haesook T. Kim, PhD, Paul G. Richardson, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Roman M Shapiro, MD, Rizwan Romee, MD, Vincent T. Ho, MD

Blood (2020) 136 (Supplement 1): 23–24.

DOI: https://doi.org/10.1182/blood-2020-135895

Published: 2020

Journal Articles

Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation

Livius Penter, Yi Zhang, PhD, Alexandra Savell, BS, Srinika Ranasinghe, PhD, Teddy Huang, BS, Nicoletta Cieri, MD PhD, Satyen H Gohil, PhD MB, BS, Wandi Zhang, BS, Shuqiang Li, PhD, Robert Zeiser, PhD, Haesook T. Kim, PhD, Kenneth J. Livak, PhD, Jerome Ritz, MD, Donna S. Neuberg, ScD, Robert J. Soiffer, MD, X. Shirley Liu, PhD, Matthew S. Davids, MD, Pavan Bachireddy, MD, Catherine J. Wu, MD

Blood (2020) 136 (Supplement 1): 34–35.

DOI: https://doi.org/10.1182/blood-2020-139487

Published: 2020

Journal Articles

DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant

Christopher J. Gibson, MD, Haesook T. Kim, PhD, H. Moses Murdock, MD, Bryan Hambley, MD, Lin Zhao, MD, Lisa Green, PhD, Mark Fleharty, Brendan Blumenstiel, Carrie Cibulskis, BSc, Christopher D Gocke, MD, Sarah Nikiforow, MD PhD, Amy E. DeZern, MD, Vincent T. Ho, MD, Richard J. Jones, MD, Niall Lennon, PhD, Jerome Ritz, MD, Robert J. Soiffer, MD, Lukasz P. Gondek, MDPhD, R. Coleman Lindsley, MD PhD

Blood (2020) 136 (Supplement 1): 26.

DOI: https://doi.org/10.1182/blood-2020-142925

Published: 2020

Journal Articles

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Blood (2020) 135 (24): 2182–2191.

DOI: https://doi.org/10.1182/blood.2019004710

Published: 2020

Includes: Supplemental data

Journal Articles

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission

Blood (2019) 134 (Supplement_1): 48.

DOI: https://doi.org/10.1182/blood-2019-125967

Published: 2019

Journal Articles

Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leukemia Undergoing Myeloablative Allogeneic Transplantation

Cindy Lynn Hickey, MDFRCPC, Haesook T. Kim, PhD, Vincent T. Ho, MD, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Jerome Ritz, MD, Rizwan Romee, MD PhD, Edwin P. Alyea, III, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD MPH, FRCPC

Blood (2019) 134 (Supplement_1): 263.

DOI: https://doi.org/10.1182/blood-2019-122257

Published: 2019

Journal Articles

Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation

Cindy Lynn Hickey, MDFRCPC, Haesook T. Kim, PhD, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Jerome Ritz, MD, Vincent T. Ho, MD, Edwin P. Alyea, III, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD MPH, FRCPC, Rizwan Romee, MD PhD

Blood (2019) 134 (Supplement_1): 4486.

DOI: https://doi.org/10.1182/blood-2019-121659

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

Lindsey E. Roeker, MD, Jennifer R. Brown, MD PhD, Peter Dreger, Oscar B Lahoud, MD, Toby A. Eyre, MBBChir, MRCP, Danielle M. Brander, MD, Alan Skarbnik, MD, Catherine C. Coombs, MD, Haesook T. Kim, PhD, Steven T Manchini, BS, Timothy J Voorhees, MD, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Harriet S Walter, Arvind K. Arumainathan, FRCPath, MBBS, MRCP,, Andrea Sitlinger, MD, Craig S. Sauter, MD, Sergio A Giralt, MD, Miguel-Angel Perales, MD, Anthony R. Mato, MDMSCE

Blood (2019) 134 (Supplement_1): 3321.

DOI: https://doi.org/10.1182/blood-2019-124140

Published: 2019

2 3 4 5

NARROW

Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease

Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial

Splenic Irradiation Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with Myelofibrosis

Allogeneic Stem Cell Cryopreservation Is Associated with Equivalent Survival and Relapse Rates with Lower Rate of Severe Chronic Gvhd

Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Phase II Clinical Trial of Abatacept for Steroid-Refractory Chronic Graft Versus Host Disease

A Phase II Study of Ruxolitinib Pre-, during- and Post-Hematopoietic Celltransplantation for Patients with Primary or Secondary Myelofibrosis

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Early Reconstitution of CD6+ T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab

Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial

Defibrotide: Real World Experience for Management of Veno-Occlusive Disease/ Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplantation

Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation

DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission

Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leukemia Undergoing Myeloablative Allogeneic Transplantation

Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only